Dr. Reddy’s Laboratories informs about press release

20 Jan 2023 Evaluate

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe’.

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Lab Share Price

1250.00 -21.05 (-1.66%)
01-Jan-2026 13:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.10
Dr. Reddys Lab 1250.00
Cipla 1499.50
Zydus Lifesciences 912.80
Lupin 2100.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×